Zoetis logo

Zoetis

Stock
Stock
ISIN: US98978V1035
Ticker: ZTS
US98978V1035
ZTS

Price

Price

Historical dividends and forecast

All dividend data

Zoetis has so far distributed $1.296 in 2024. The next dividend will be paid on 03.12.2024


$0.833

CHART BY

Frequently asked questions

What is Zoetis's market capitalization?

The market capitalization of Zoetis is $79.26B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Zoetis's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Zoetis is 33.03. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Zoetis?

Zoetis's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $5.319. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Zoetis's stock?

Currently, 16 analysts cover Zoetis's stock, with a consensus target price of $211.69. Analyst ratings provide insights into the stock's expected performance.

What is Zoetis's revenue over the trailing twelve months?

Over the trailing twelve months, Zoetis reported a revenue of $9.15B.

Is Zoetis paying dividends?

Yes, Zoetis is paying dividends. The next payment is scheduled for 03.12.2024, with an expected amount of .

What is the EBITDA for Zoetis?

Zoetis's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $3.84B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Zoetis?

Zoetis has a free cash flow of $1.54B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

What is the 5-year beta of Zoetis's stock?

The 5-year beta for Zoetis is 0.90. A beta value indicates the stock's volatility relative to the market; a beta greater than 1 means higher volatility.

How many employees does Zoetis have, and what sector and industry does it belong to?

Zoetis employs approximately 14,100 people. It operates in the Health Care sector, specifically within the Biotechnology & Drugs industry.

What is the free float of Zoetis's shares?

The free float of Zoetis is 450.25M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap

 
$79.26B

5Y beta

 
0.90

EPS (TTM)

 
$5.319

Free Float

 
450.25M

P/E ratio (TTM)

 
33.03

Revenue (TTM)

 
$9.15B

EBITDA (TTM)

 
$3.84B

Free Cashflow (TTM)

 
$1.54B

Pricing

1D span
$174.86$178.12
52W span
$144.80$201.92

Analyst Ratings

The price target is $211.69 and the stock is covered by 16 analysts.

Buy

15

Hold

1

Sell

0

Information

Zoetis Inc. is a global animal health company. The Company is focused on the discovery, development, manufacture and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests and precision animal health. The Company operates through two segments: the United States (U.S.) and International. Within each of these operating segments, it offers a diversified product portfolio, including parasiticides, vaccines, dermatology, anti-infectives, pain and sedation, other pharmaceutical, and animal health diagnostics, for both companion animal and livestock customers. It directly markets its products in approximately 45 countries across North America, Europe, Africa, Asia, Australia and South America. It is engaged in commercializing products across eight core species: dogs, cats and horses (collectively, companion animals) and cattle, poultry, swine, fish and sheep (collectively, livestock).

14,100

Biotechnology & Drugs

Health Care

Identifier

ISIN

US98978V1035

Primary Ticker

ZTS

Knockouts

Join the conversation